Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Importance Patients with hepatocellular carcinoma showing macroscopic vascular invasion
have a poor prognosis. Sorafenib is the sole treatment option for these patients, with …

Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …

Hepatocellular carcinoma (HCC), the fifth most common cancer that predominantly occurs in
liver cirrhosis patients, requires staging systems to design treatments. The barcelona clinic …

Intravascular tumor extension, also known as tumor thrombus, can occur in many different
types of cancer. Those with the highest proclivity include Wilm's tumor, renal cell carcinoma …

Hepatocellular carcinoma is one of the most frequent malignant tumors worldwide: Portal
vein tumor thrombosis (PVTT) occurs in about 35%-50% of patients and represents a strong …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

Portal vein tumor thrombosis (PVTT) is a common phenomenon in hepatocellular carcinoma
(HCC). Compared to HCC without PVTT, HCC with PVTT is characterized by an aggressive …

Hepatic resection represents the first-line treatment for patients with resectable
hepatocellular carcinoma (HCC). However, the 5-year recurrence rates of HCC after surgery …